The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $56.08

Today's change-0.24 -0.43%
Updated October 23 4:01 PM EDT. Delayed by at least 15 minutes.
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $56.08

Today's change-0.24 -0.43%
Updated October 23 4:01 PM EDT. Delayed by at least 15 minutes.

Reversal following new 52-week high

Abbott Laboratories closed lower Monday, dropping (U.S.)$0.24 or 0.43% to (U.S.)$56.08 after setting a new 52-week high. Over the last five days, shares have gained 2.65% and are currently 1.07% off of the 52-week high. Shares have outperformed the S&P 500 by 18.68% during the last year.

Key company metrics

  • Open(U.S.) $56.21
  • Previous close(U.S.) $56.32
  • High(U.S.) $56.69
  • Low(U.S.) $56.07
  • Bid / Ask-- / --
  • YTD % change+46.00%
  • Volume4,709,045
  • Average volume (10-day)5,294,860
  • Average volume (1-month)5,945,349
  • Average volume (3-month)5,688,793
  • 52-week range(U.S.) $37.38 to (U.S.) $56.69
  • Beta1.57
  • Trailing P/E46.24×
  • P/E 1 year forward22.54×
  • Forward PEG1.96×
  • Indicated annual dividend(U.S.) $1.06
  • Dividend yield1.89%
  • Trailing EPS(U.S.) $1.21
Updated October 23 4:01 PM EDT. Delayed by at least 15 minutes.

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue6,8296,6376,3355,333
Total other revenue--------
Total revenue6,8296,6376,3355,333
Gross profit3,9723,4643,2913,023
Total cost of revenue2,8573,1733,0442,310
Total operating expense6,0196,2106,5374,385
Selling / general / administrative2,0992,1322,2991,606
Research & development562513541338
Depreciation / amortization501392522121
Interest expense (income), net operating--------
Unusual expense (income)----13110
Other operating expenses, total--------
Operating income810427-202948
Interest income (expense), net non-operating-182-214-226-153
Gain (loss) on sale of assets--------
Other--------
Income before tax626295736875
Income after tax561270386765
Income tax, total6525350110
Net income603283419798
Total adjustments to net income--------
Net income before extra. items561270386765
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items561270386765
Inc. avail. to common incl. extra. items603283419798
Diluted net income603283419798
Dilution adjustment--------
Diluted weighted average shares1,7541,7411,7351,484
Diluted EPS excluding extraordinary itemsvalue per share0.320.160.220.52
Dividends per sharevalue per share0.270.270.270.26
Diluted normalized EPSvalue per share0.320.160.260.52